Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9234362rdf:typepubmed:Citationlld:pubmed
pubmed-article:9234362lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C0040077lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C0008562lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C1708632lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:9234362lifeskim:mentionsumls-concept:C1522485lld:lifeskim
pubmed-article:9234362pubmed:issue8lld:pubmed
pubmed-article:9234362pubmed:dateCreated1997-9-18lld:pubmed
pubmed-article:9234362pubmed:abstractTextThe identity and pharmacology of the rapidly formed radiolabeled metabolites formed following i.v. injection of C-11 thymidine (TdR) labeled in the 5-methyl-position are being studied in animal models and patients with cancer. A high performance liquid chromatographic (HPLC) procedure has been developed for the separation of these metabolites including thymine, dihydrothymine, beta-ureidoisobutyric acid, and beta-aminoisobutyric acid from plasma and tissue extracts. Information obtained regarding the pharmacokinetics of the metabolites are being used to generate mathematical models for C-11 TdR incorporation rates into DNA.lld:pubmed
pubmed-article:9234362pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234362pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234362pubmed:languageenglld:pubmed
pubmed-article:9234362pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234362pubmed:citationSubsetIMlld:pubmed
pubmed-article:9234362pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234362pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234362pubmed:statusMEDLINElld:pubmed
pubmed-article:9234362pubmed:monthNovlld:pubmed
pubmed-article:9234362pubmed:issn0969-8051lld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:AndersonJ HJHlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:HiltonJJlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:WilsonA AAAlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:DannalsR FRFlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:RavertH THTlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:WongD FDFlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:ContiP SPSlld:pubmed
pubmed-article:9234362pubmed:authorpubmed-author:AlauddinM MMMlld:pubmed
pubmed-article:9234362pubmed:issnTypePrintlld:pubmed
pubmed-article:9234362pubmed:volume21lld:pubmed
pubmed-article:9234362pubmed:ownerNLMlld:pubmed
pubmed-article:9234362pubmed:authorsCompleteYlld:pubmed
pubmed-article:9234362pubmed:pagination1045-51lld:pubmed
pubmed-article:9234362pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:meshHeadingpubmed-meshheading:9234362-...lld:pubmed
pubmed-article:9234362pubmed:year1994lld:pubmed
pubmed-article:9234362pubmed:articleTitleHigh performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies.lld:pubmed
pubmed-article:9234362pubmed:affiliationDepartment of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.lld:pubmed
pubmed-article:9234362pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9234362pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234362lld:pubmed